N-Tosyl-5-bromo-4,7-diazaindole
Catalog No.: BK711A
CAS.RN：1201186-54-0
Molecular Formula: C13H10BrN3O2S
Molecular Weight: 352.21 g/mol
Purity: NLT 98%
Intermediates of Upadacitinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA1R4F | Upadacitinib API | 1310726-60-3 |
| BK9C81 | Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate | 2095311-51-4 |
| BK319Y | (3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt | 2095311-49-0 |
| BK5B3X | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester | 1869118-24-0 |
| BK711A | N-Tosyl-5-bromo-4,7-diazaindole | 1201186-54-0 |
| BK35UU | 5-Bromo-4,7-diazaindole | 875781-43-4 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
